Popular Articles

Recent Releases: New Res On HIV Testing In The U.S. Available, Nationwide HIV Campaign Announced
The Kaiser Family Foundation, ahead of National HIV Testing Day on Saturday, has released new and updated informational res on HIV testing in the U.S., including a fact sheet that provides HIV testing statistics, policies and CDC recommendations. In addition, the Foundation released two survey briefs, which examine the public"s attitudes, experiences and knowledge related to HIV testing, one of which focuses on black residents. The briefs are based on the 2009 Survey of Americans on HIV/AIDS released this spring. Information regarding HIV testing by state also is available through statehealthfacts.org (Kaiser Family Foundation release, 6/24).
generic viagra online
U.N. Agencies Increase Request For Foreign Donations To Zimbabwe
In the midst of Zimbabwe"s growing humanitarian crisis, U.N. agencies on Monday released a revised statement of appeal for foreign donations totaling $718 million for "food, clean water, AIDS medicines and other aid - up from an estimate of $550 million in November," the AP/Washington Post reports (Shaw, AP/Washington Post, 6/1).
News of the day
GP Bodies Support Guidelines For Use Of Patient Records In Medical Research
The two leading bodies representing GPs in the UK have backed a call by the Wellcome Trust for clearer guidance for GPs to ensure medical records can be safely used in research.
Medical Devices

Artificial Liver For Drug Tests

If you have hay fever, headaches or a cold, it"s only a short way to the nearest chemist. The drugs, on the other hand, can take eight to ten years to develop. Until now animal experiments have been an essential step, yet they continue to raise ethical issues. "Our artificial organ systems are aimed at offering an alternative to animal experiments," says Professor Heike Mertsching of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart. "Particularly as humans and animals have different metabolisms. 30 per cent of all side effects come to light in clinical trials." The test system, which Professor Mertsching has developed jointly with Dr. Johanna Schanz, should in future give pharmaceutical companies greater security and shorten the path to new drugs. Both researchers received the "Human-centered Technology" prize for their work. "The special feature, in our liver model for example, is a functioning system of blood vessels," says Dr. Schanz. "This creates a natural environment for cells." Traditional models do not have this, and the cells become inactive. "We don"t build artificial blood vessels for this, but use existing ones - from a piece of pig"s intestine." All of the pig cells are removed, but the blood vessels are preserved. Human cells are then seeded onto this structure - hepatocytes, which, as in the body, are responsible for transforming and breaking down drugs, and endothelial cells, which act as a barrier between blood and tissue cells. In order to simulate blood and circulation, the researchers put the model into a computer-controlled bioreactor with flexible tube pump, developed by the IGB. This enables the nutrient solution to be fed in and carried away in the same way as in veins and arteries in humans. "The cells were active for up to three weeks," says Dr. Schanz. "This time was sufficient to analyze and evaluate the functions. A longer period of activity is possible, however." The researchers established that the cells work in a similar way to those in the body. They detoxify, break down drugs and build up proteins. These are important pre-conditions for drug tests or transplants, as the effect of a substance can change when transformed or broken down - many drugs are only metabolized into their therapeutic active form in the liver, while others can develop poisonous substances. The researchers have demonstrated the basic possibilities for use of the tissue models - liver, skin, intestine and windpipe. At the moment, the test system is being examined. Within two years it could provide a safer alternative to animal experiments. Heike Mertsching Fraunhofer-Gesellschaft


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):